{"id":115096,"date":"2016-09-20T09:33:51","date_gmt":"2016-09-20T09:33:51","guid":{"rendered":"http:\/\/healthmedicinet.com\/i\/gsk-names-emma-walmsley-as-new-chief-executive\/"},"modified":"2016-09-20T09:33:51","modified_gmt":"2016-09-20T09:33:51","slug":"gsk-names-emma-walmsley-as-new-chief-executive","status":"publish","type":"post","link":"http:\/\/healthmedicinet.com\/i\/gsk-names-emma-walmsley-as-new-chief-executive\/","title":{"rendered":"GSK names Emma Walmsley as new chief executive"},"content":{"rendered":"<p class=\"canvas-text Mb(1.0em) Mb(0)--sm Mt(0.8em)--sm canvas-atom\">LONDON (AP) \u2014 Drugmaker GlaxoSmithKline says Emma Walmsley will be the company&#8217;s new chief executive, replacing Andrew Witty when he retires next March.<\/p>\n<p class=\"canvas-text Mb(1.0em) Mb(0)--sm Mt(0.8em)--sm canvas-atom\">Walmsley currently runs the company&#8217;s consumer healthcare division, established as part of a deal in which GSK swapped its cancer-drug unit for Novartis&#8217;s vaccine business.<\/p>\n<p class=\"canvas-text Mb(1.0em) Mb(0)--sm Mt(0.8em)--sm canvas-atom\">She joined GSK in 2010 from L&#8217;Oreal, where she held roles in the U.K., Europe and China.<\/p>\n<p class=\"canvas-text Mb(1.0em) Mb(0)--sm Mt(0.8em)--sm canvas-atom\">Walmsley says Tuesday that GSK has momentum and &#8220;the opportunity and the potential to create meaningful benefits for patients, consumers and our shareholders.&#8221;<\/p>\n<p class=\"canvas-text Mb(1.0em) Mb(0)--sm Mt(0.8em)--sm canvas-atom\">GSK and other large pharmaceutical companies are regrouping amid competition from generic drugmakers, shedding units that aren&#8217;t central to their businesses and focusing on their strengths.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LONDON (AP) \u2014 Drugmaker GlaxoSmithKline says Emma Walmsley will be the company&#8217;s new chief executive, replacing Andrew Witty when he retires next March. Walmsley currently runs the company&#8217;s consumer healthcare division, established as part of a deal in which GSK swapped its cancer-drug unit for Novartis&#8217;s vaccine business. She joined GSK in 2010 from L&#8217;Oreal, <a class=\"read-more-link\" href=\"http:\/\/healthmedicinet.com\/i\/gsk-names-emma-walmsley-as-new-chief-executive\/\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-115096","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts\/115096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/comments?post=115096"}],"version-history":[{"count":0,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts\/115096\/revisions"}],"wp:attachment":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/media?parent=115096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/categories?post=115096"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/tags?post=115096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}